In Allergan USA, Inc. v. MSN Laboratories Private Ltd., the US Court of Appeals for the Federal Circuit held that a first-filed, first-issued, later-expiring claim cannot be invalidated under the doctrine of obviousness-type-double patenting (ODP) by a later-filed, later-issued, earlier-expiring reference claim having a common priority date.
Source link
